SCHEMBL22968581

SCHEMBL22968581

CCC/C=C\C=N\Oc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.34
MAOB P27338 1/20 0.31
CA4 P22748 1/20 0.31
AOC3 Q16853 1/20 0.31
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
FAAH O00519 2/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30
RELA Q04206 1/20 0.30
NPC1 O15118 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
HTT P42858 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22129143 0.76 LTA4H (0.43) LTA4HCA4AOC3ALDH1A1KDM4E
SCHEMBL25566852 0.73 LTA4H (0.33) LTA4HCA4AOC3
SCHEMBL18672790 0.73 LTA4H (0.43) LTA4HMAOBALDH1A1SMN1; SMN2FAAH
SCHEMBL9945371 0.71 LTA4H (0.38) LTA4HMAOBCA4ALDH1A1CHRNB2
SCHEMBL16760862 0.71 CA4 (0.42) LTA4HCA4ALDH1A1SMN1; SMN2FAAH
SCHEMBL28078005 0.69 LTA4H (0.42) LTA4HCA4AOC3SMN1; SMN2CHRNB2
SCHEMBL15242512 0.69 MEN1 (0.39) ALDH1A1KDM4ESMN1; SMN2LMNAMEN1
SCHEMBL16506381 0.69 MEN1 (0.39) ALDH1A1KDM4ESMN1; SMN2LMNAMEN1
SCHEMBL16506380 0.69 MEN1 (0.39) ALDH1A1KDM4ESMN1; SMN2LMNAMEN1
SCHEMBL28231064 0.69 LTA4H (0.36) LTA4HMAOBCA4AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021023843-A1 IMPROVED SYNTHETIC METHODS OF MAKING (2H-1,2,3-TRIAZOL-2-YL)PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2021-02-11 WO disclosed